New test expands access to early Alzheimer’s assessment, streamlining diagnostic pathways and improving referral efficiency
The study concluded that elevated levels of two proteins help predict how a person will recover from a traumatic brain injury (TBI), providing important information to determine appropriate care
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
It is the first approved blood test that can predict likely progression to Alzheimer's Disease up to six years in advance
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
_256_384.png){kind=logo}
Results from these studies are expected to be released by 2023. If outcomes from these initial pilots are positive, the studies will be expanded to involve around 1 million participants in 2024 and 2025
Encouraging early detection and breaking the silence around men’s health
Roche also shared the design of its upcoming Phase III TRONTIER 1 and 2 trials investigating trontinemab in people with early symptomatic Alzheimer’s disease
Women Health Card was launched exclusively for women health workers of the Tiruchirappalli City Corporation
Subscribe To Our Newsletter & Stay Updated
